Figure 3: Effect of resveratrol treatment on estimated glomerularfiltration rate (eGRF). Changes of renal function assessed by the estimated glomerular filtration rate (eGFR, CKD-EPI) arepresented as median values of 6 week/Baseline, 12 week/Baseline and open label Wash out/Baseline ratios in male (A) and 6 week/ Baseline and 12 week/Baseline ratios in female (B) IgAN patients treated with Resveratrol or Placebo.*, p<0.05.